Abstract
Equal doses of veralipride have been given to 12 healthy volunteers by three different administrations-intravenous infusion, oral solution, and oral capsule-in a randomized cross-over design. After the intake of the solution, but not after infusion or capsules, two maximum plasma concentrations have been observed and interpreted, according to a double-site model for drug absorption.
This is a preview of subscription content, log in via an institution to check access.
References
L. F. Prescott. Gastrointestinal absorption of drugs.Med. Clin. N. Am. 58:5–17 (1974).
B. Dahlstrom and L. Applzow. Pharmacokinetic interpretation of the enterohepatic recirculation and first-pass elimination of morphine in the rat.J. Pharmacokin. Biopharm. 6:505–519 (1978).
P. Veng-Pedersen and R. Miller. Pharmacokinetics of doxycycline reabsorption.J. Pharm. Sci. 69:204–207 (1980).
P. Veng-Pedersen and R. Miller. Pharmacokinetics and bioavailability of cimetidine in humans.J. Pharm. Sci. 69:394–398 (1980).
W. Colburn. Pharmacokinetic and biopharmaceutic parameters during enterohepatic circulation of drugs.J. Pharm. Sci. 71:131–133 (1982).
J. L. Steimer, Y. Plusquellec, A. Guillaume, and J. F. Boisvieux. A time-lag model for pharmacokinetics of drugs subject to enterohepatic circulation.J. Pharm. Sci. 71:297–302 (1982).
Y. Plusquellec and J. L. Steimer. An analytical solution for a class of delay-differential equations in pharmacokinetic compartment modeling.Math. Biosci. 70:39–56 (1984).
D. Brockmeier, H. G. Grigoleit and H. Leonhardt. The absorption of piretanide from the gastro-intestinal tract is site-dependent.Eur. J. Clin. Pharmacol. 30:79–82 (1986).
S. Staveris, G. Houin, J. P. Tillement, G. Jamet, M. Schneider, L. Jung, and J. C. Koffel. Primary dose-dependent pharmacokinetic study of veralipride: A new regulator of postmenopausal “hot flushes.”J. Pharm. Sci. 74:94–96 (1985).
W. Kubler. Pharmacokinetics of gastrointestinal absorption. In E. Gladtke and H. M. Von Hattingberg (eds.)Pharmacokinetics, an introduction, Springer Verlag, Berlin, 1979, pp. 68–90.
R. Suverkrup. Discontinuous absorption processes in pharmacokinetic models.J. Pharm. Sci. 68:1395–1400 (1979).
S. Staveris, L. Jung, G. Jamet, and J. C. Koffel. Quantitative analysis of veralipride in plasma and urine by G. C. Ms and G. C. Fid.J. Chromatogr. 338:79–88 (1985).
P. D'Athis, M. O. Richard, D. Delauture, E. Rey, M. Bouvier D'Yvoire, E. Clement and G. Olive. Etude comparative des biodisponibilités de deux formes de spironolactone. Application a la rationalisation des posologies.Therapie 38:443–450 (1981).
D. W. Marquardt. An algorithm for least squares estimation of non-linear parameters.J. Soc. Indust. Appl Math. 11:431–441 (1963).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Plusquellec, Y., Campistron, G., Staveris, S. et al. A double-peak phenomenon in the pharmacokinetics of veralipride after oral administration: A double-site model for drug absorption. Journal of Pharmacokinetics and Biopharmaceutics 15, 225–239 (1987). https://doi.org/10.1007/BF01066319
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01066319